Behavioural deficits associated with maternal immune activation in the rat model of schizophrenia

Behavioural Brain Research

Volumn 225, Issue 1, 2011, Pages 382-387

  Wolff, Amy R ^a   Cheyne, Kirsten R ^a   Bilkey, David K ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Context; Immune; Memory; Rat; Reversal; Schizophrenia

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DISEASE MODEL; FEMALE; LEARNING; MATERNAL DISEASE; MATERNAL IMMUNE ACTIVATION; MEMORY DISORDER; NONHUMAN; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; RAT; REARING; RECOGNITION; SCHIZOPHRENIA; STIMULUS RESPONSE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIORAL SYMPTOMS; DISCRIMINATION (PSYCHOLOGY); DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; POLY I-C; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RECOGNITION (PSYCHOLOGY); REVERSAL LEARNING; SCHIZOPHRENIA;

EID: 80052408374     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.07.033     Document Type: Article

References (77)

1. Adams W., Kendell R.E., Hare E.H., Munk-Jorgensen P. Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. An analysis of Scottish, English, and Danish data. Br J Psychiatry 1993, 163:522-534.
2. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 2006, 32:200-202.
3. Patterson P.H. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 2002, 12:115-118.
4. Nawa H., Takahashi M., Patterson P.H. Cytokine and growth factor involvement in schizophrenia - support for the developmental model. Mol Psychiatry 2000, 5:594-603.
5. Gilmore J.H., Jarskog L.F. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr Res 1997, 24:365-367.
6. Meyer U., Feldon J., Schedlowski M., Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 2005, 29:913-947.
7. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 2006, 59:546-554.
8. Zuckerman L., Rehavi M., Nachman R., Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 2003, 28:1778-1789.
9. Zuckerman L., Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 2005, 39:311-323.
10. Zuckerman L., Weiner I. Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation. Psychopharmacology (Berl) 2003, 169:308-313.
11. Piontkewitz Y, Arad M, Weiner I. Risperidone Administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. Schizophr Bull 2010 (Epub ahead of print).
12. Piontkewitz Y., Assaf Y., Weiner I. Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. Biol Psychiatry 2009, 66:1038-1046.
13. Lewis D.A., Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 2000, 28:325-334.
14. Austin J. Schizophrenia: an update and review. J Genet Couns 2005, 14:329-340.
15. Bitanihirwe B.K., Weber L., Feldon J., Meyer U. Cognitive impairment following prenatal immune challenge in mice correlates with prefrontal cortical AKT1 deficiency. Int J Neuropsychopharmacol 2010, 1-16.
16. Ibi D., Nagai T., Kitahara Y., Mizoguchi H., Koike H., Shiraki A., et al. Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood. Neurosci Res 2009, 64:297-305.
17. Ito H.T., Smith S.E., Hsiao E., Patterson P.H. Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring. Brain Behav Immun 2010, 24:930-941.
18. Meyer U., Knuesel I., Nyffeler M., Feldon J. Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis. Psychopharmacology 2010, 208:531-543.
19. Meyer U., Nyffeler M., Yee B.K., Knuesel I., Feldon J. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 2008, 22:469-486.
20. Bevins R.A., Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat Protoc 2006, 1:1306-1311.
21. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 1988, 31:47-59.
22. Dix S.L., Aggleton J.P. Extending the spontaneous preference test of recognition: evidence of object-location and object-context recognition. Behav Brain Res 1999, 99:191-200.
23. Yogev H., Hadar U., Gutman Y., Sirota P. Perseveration and over-switching in schizophrenia. Schizophr Res 2003, 61:315-321.
24. Yogev H., Sirota P., Gutman Y., Hadar U. Latent inhibition and overswitching in schizophrenia. Schizophr Bull 2004, 30:713-726.
25. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006, 26:4752-4762.
26. Han X., Li N., Meng Q., Shao F., Wang W. Maternal immune activation impairs reversal learning and increases serum tumor necrosis factor-alpha in offspring. Neuropsychobiology 2011, 64:9-14.
27. Cohen J.D., Barch D.M., Carter C., Servan-Schreiber D. Context-processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks. J Abnorm Psychol 1999, 108:120-133.
28. Cohen J.D., Braver T.S., O'Reilly R.C. A computational approach to prefrontal cortex, cognitive control and schizophrenia: recent developments and current challenges. Philos Trans R Soc Lond 1996, 351:1515-1527.
29. Cohen J.D., Servan-Schreiber D. Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. Psychol Rev 1992, 99:45-77.
30. Servan-Schreiber D., Cohen J.D., Steingard S. Schizophrenic deficits in the processing of context. A test of a theoretical model. Arch Gen Psychiatry 1996, 53:1105-1112.
31. Porton B., Rodriguiz R.M., Phillips L.E., Gilbert J.Wt., Feng J., Greengard P., et al. Mice lacking synapsin III show abnormalities in explicit memory and conditioned fear. Genes Brain Behav 2010, 9:257-268.
32. Csernansky J.G., Martin M., Shah R., Bertchume A., Colvin J., Dong H. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Neuropsychopharmacology 2005, 30:2135-2143.
33. Martin M.V., Dong H., Bertchume A., Csernansky J.G. Low dose quetiapine reverses deficits in contextual and cued fear conditioning in rats with excitotoxin-induced hippocampal neuropathy. Pharmacol Biochem Behav 2005, 82:263-269.
34. Qiu S., Korwek K.M., Pratt-Davis A.R., Peters M., Bergman M.Y., Weeber E.J. Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice. Neurobiol Learn Mem 2006, 85:228-242.
35. Kelly M.P., Stein J.M., Vecsey C.G., Favilla C., Yang X., Bizily S.F., et al. Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia. Mol Psychiatry 2009, 14:398-415. 347.
36. Brzozka M.M., Radyushkin K., Wichert S.P., Ehrenreich H., Rossner M.J. Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol Psychiatry 2010, 68:33-40.
37. Ehrlichman R.S., Luminais S.N., White S.L., Rudnick N.D., Ma N., Dow H.C., et al. Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions. Brain Res 2009, 1294:116-127.
38. Chess A.C., Landers A.M., Bucci D.J. L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning. Behav Brain Res 2009, 201:325-331.
39. Le Cozannet R., Fone K.C., Moran P.M. Phencyclidine withdrawal disrupts episodic-like memory in rats: reversal by donepezil but not clozapine. Int J Neuropsychopharmacol 2010, 13:1011-1020.
40. Li J.T., Su Y.A., Guo C.M., Feng Y., Yang Y., Huang R.H., et al. Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats. Eur J Pharmacol 2011, 652:65-72.
41. Liu P., Bilkey D.K. The effect of excitotoxic lesions centered on the hippocampus or perirhinal cortex in object recognition and spatial memory tasks. Behav Neurosci 2001, 115:94-111.
42. Liu P., Jarrard L.E., Bilkey D.K. Excitotoxic lesions of the pre- and parasubiculum disrupt object recognition and spatial memory processes. Behav Neurosci 2001, 115:112-124.
43. Lever C., Burton S., O'Keefe J. Rearing on hind legs, environmental novelty, and the hippocampal formation. Rev Neurosci 2006, 17:111-133.
44. Aggleton J.P., Keen S., Warburton E.C., Bussey T.J. Extensive cytotoxic lesions involving both the rhinal cortices and area TE impair recognition but spare spatial alternation in the rat. Brain Res Bull 1997, 43:279-287.
45. Aggleton J.P., Albasser M.M., Aggleton D.J., Poirier G.L., Pearce J.M. Lesions of the rat perirhinal cortex spare the acquisition of a complex configural visual discrimination yet impair object recognition. Behav Neurosci 2010, 124:55-68.
46. Barker G.R., Bird F., Alexander V., Warburton E.C. Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. J Neurosci 2007, 27:2948-2957.
47. Weiner I., Feldon J. The switching model of latent inhibition: an update of neural substrates. Behav Brain Res 1997, 88:11-25.
48. Weiner I., Feldon J., Ben-Shahar O. Simultaneous brightness discrimination and reversal: the effects of amphetamine administration in the two stages. Pharmacol Biochem Behav 1986, 25:939-942.
49. Murray G.K., Cheng F., Clark L., Barnett J.H., Blackwell A.D., Fletcher P.C., et al. Reinforcement and reversal learning in first-episode psychosis. Schizophr Bull 2008, 34:848-855.
50. Meyer U., Feldon J., Fatemi S.H. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev 2009, 33:1061-1079.
51. Morice R. Cognitive inflexibility and pre-frontal dysfunction in schizophrenia and mania. Br J Psychiatry 1990, 157:50-54.
52. Clarke H.F., Dalley J.W., Crofts H.S., Robbins T.W., Roberts A.C. Cognitive inflexibility after prefrontal serotonin depletion. Science (New York, NY) 2004, 304:878-880.
53. Yee B.K., Rawlins J.N. A comparison between the effects of medial septal lesions and entorhinal cortex lesions on performance of nonspatial working memory tasks and reversal learning. Behav Brain Res 1998, 94:281-300.
54. Neill J.C., Sarkisian M.R., Wang Y., Liu Z., Yu L., Tandon P., et al. Enhanced auditory reversal learning by genetic activation of protein kinase C in small groups of rat hippocampal neurons. Brain Res Mol Brain Res 2001, 93:127-136.
55. Harrison P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 2004, 174:151-162.
56. Beckmann H. Developmental malformations in cerebral structures of schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 1999, 249(Suppl. 4):44-47.
57. Weinberger D.R. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 1999, 45:395-402.
58. Sutherland R.J., Whishaw I.Q., Kolb B. A behavioural analysis of spatial localization following electrolytic, kainate- or colchicine-induced damage to the hippocampal formation in the rat. Behav Brain Res 1983, 7:133-153.
59. Sutherland R.J., Whishaw I.Q., Regehr J.C. Cholinergic receptor blockade impairs spatial localization by use of distal cues in the rat. J Comp Physiol Psychol 1982, 96:563-573.
60. Moses S.N., Sutherland R.J., McDonald R.J. Differential involvement of amygdala and hippocampus in responding to novel objects and contexts. Brain Res Bull 2002, 58:517-527.
61. Anderson M.I., Killing S., Morris C., O'Donoghue A., Onyiagha D., Stevenson R., et al. Behavioral correlates of the distributed coding of spatial context. Hippocampus 2006, 16:730-742.
62. Jenkins T.A., Amin E., Pearce J.M., Brown M.W., Aggleton J.P. Novel spatial arrangements of familiar visual stimuli promote activity in the rat hippocampal formation but not the parahippocampal cortices: a c-fos expression study. Neuroscience 2004, 124:43-52.
63. Vann S.D., Brown M.W., Erichsen J.T., Aggleton J.P. Fos imaging reveals differential patterns of hippocampal and parahippocampal subfield activation in rats in response to different spatial memory tests. J Neurosci 2000, 20:2711-2718.
64. Zhu X.O., McCabe B.J., Aggleton J.P., Brown M.W. Differential activation of the rat hippocampus and perirhinal cortex by novel visual stimuli and a novel environment. Neurosci Lett 1997, 229:141-143.
65. Aggleton J.P., Brown M.W. Contrasting hippocampal and perirhinal cortex function using immediate early gene imaging. Q J Exp Psychol 2005, 58:218-233.
66. Hess U.S., Lynch G., Gall C.M. Regional patterns of c-fos mRNA expression in rat hippocampus following exploration of a novel environment versus performance of a well-learned discrimination. J Neurosci 1995, 15:7796-7809.
67. Hunsaker M.R., Mooy G.G., Swift J.S., Kesner R.P. Dissociations of the medial and lateral perforant path projections into dorsal DG, CA3, and CA1 for spatial and nonspatial (visual object) information processing. Behav Neurosci 2007, 121:742-750.
68. Van Cauter T., Poucet B., Save E. Delay-dependent involvement of the rat entorhinal cortex in habituation to a novel environment. Neurobiol Learn Mem 2008, 90:192-199.
69. Myhrer T. Exploratory behavior and reaction to novelty in rats with hippocampal perforant path systems disrupted. Behav Neurosci 1988, 102:356-362.
70. Csernansky J.G., Wang L., Jones D., Rastogi-Cruz D., Posener J.A., Heydebrand G., et al. Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. Am J Psychiatry 2002, 159:2000-2006.
71. Arnold S.E., Franz B.R., Gur R.C., Gur R.E., Shapiro R.M., Moberg P.J., et al. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 1995, 152:738-748.
72. Benes F.M., Sorensen I., Bird E.D. Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 1991, 17:597-608.
73. Zaidel D.W., Esiri M.M., Harrison P.J. Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. Am J Psychiatry 1997, 154:812-818.
74. Heckers S., Konradi C. Hippocampal neurons in schizophrenia. J Neural Transm 2002, 109:891-905.
75. Goldman M.B., Mitchell C.P. What is the functional significance of hippocampal pathology in schizophrenia?. Schizophr Bull 2004, 30:367-392.
76. Heckers S. Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 2001, 11:520-528.
77. Schmajuk N.A. Hippocampal dysfunction in schizophrenia. Hippocampus 2001, 11:599-613.